Actuate Therapeutics, Inc. (ACTU) stock
ACTUNasdaqPharmaceutical PreparationsFiscal year ends December 31
$0.25−0.02 (-6.12%)
Close on Nov 17, 2026Market cap $6.04MP/E –Yield –
Actuate Therapeutics price to book ratio
The price-to-book ratio is market cap divided by shareholders' equity.
Actuate Therapeutics's price to book ratio was 7.3× on Nov 11, 2026, against 16.2× a year earlier.
Price to Book Ratio at the end of each year
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| 2026 | Nov 11, 2026 | 7.3× | −5.7 |
| 2025 | Dec 31, 2025 | 13.0× | −16.0 |
| 2024 | Dec 31, 2024 | 29.0× | – |
See a number that looks wrong?